Consent for Molecular Profiling
Patient Consent
As part of your cancer care plan, your physician has ordered molecular testing from Caris in order to better understand your tumor’s biomarkers and help identify changes that control cell growth. Results from this test may help guide your personal treatment plan. In order to begin testing, patient consent for molecular profiling is required. Please complete the electronic consent form by clicking the button on the right.
Additional PDF Consent Forms in Multiple Languages:
Choose the appropriate state and language consent form below and return to Caris. Email completed form to CustomerSupport@CarisLS.com, or fax to 866-479-4925.
English
Spanish
Arabic
Chinese
-Simplified
-Traditional
French Canadian
French Creole
Italian
Portuguese
Russian
Tagalog
Vietnamese
English
Spanish
Amharic
Arabic
Chinese
-Simplified
-Traditional
French
French Creole
German
Hmong
Indonesian
Italian
Karen
Korean
Laotian
Portuguese
Russian
Tagalog
Vietnamese
English
Spanish
Amharic
Arabic
Chinese
-Simplified
–Traditional
Japanese
Korean
Russian
Tagalog
Thai
Vietnamese
English
Spanish
Arabic
Bengali
Chinese – Simplified
French Creole
Italian
Korean
Polish
Russian
Yiddish
English
Spanish
Arabic
Chinese – Simplified
Japanese
Korean
Mon-Khmer Cambodian
Romanian
Russian
Ukrainian
Vietnamese
Share Your Molecular Profiling Story
Have you or a loved one received molecular profiling from Caris? If so, we’d love to hear about your cancer journey and how molecular profiling played a role. Your story may provide strength and support to others who are battling cancer.
Discover
More
Hear from those who courageously share their cancer journey including Caris molecular profiling, offering valuable insights and perspectives that go beyond the statistics and outcomes.